Valeo Financial Advisors LLC Sells 3,726 Shares of CVS Health Corporation $CVS

Key Points

• Valeo Financial Advisors LLC reduced its stake in CVS Health by 12.2%, selling 3,726 shares and retaining 26,763 shares valued at approximately $1.85 million.
• CVS Health received multiple rating upgrades from various analysts, with UBS raising the price target from $67 to $79 and an average target price of $78.25.
• The company declared a quarterly dividend of $0.665 per share, with the next payment scheduled for November 3rd, representing an annualized yield of 3.5%.

Valeo Financial Advisors LLC lowered its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 12.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,763 shares of the pharmacy operator's stock after selling 3,726 shares during the quarter. Valeo Financial Advisors LLC's holdings in CVS Health were worth $1,846,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Bell Investment Advisors Inc grew its stake in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock worth $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC grew its stake in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 202 shares during the last quarter. ORG Partners LLC grew its stake in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 377 shares during the last quarter. Saudi Central Bank purchased a new stake in shares of CVS Health during the first quarter worth about $34,000. Finally, Livelsberger Financial Advisory purchased a new stake in shares of CVS Health during the second quarter worth about $35,000. Institutional investors own 80.66% of the company's stock.

Wall Street Analyst Weigh In

CVS has been the topic of a number of research analyst reports. UBS Group upgraded CVS Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $67.00 to $79.00 in a research note on Monday, August 18th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research note on Sunday, September 21st. Wolfe Research raised their price objective on CVS Health from $80.00 to $85.00 and gave the stock an "outperform" rating in a research note on Monday, September 22nd. Bernstein Bank reduced their price objective on CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a research note on Wednesday, July 16th. Finally, Morgan Stanley raised their price objective on CVS Health from $80.00 to $82.00 and gave the stock an "overweight" rating in a research note on Friday, August 1st. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $78.25.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.22% of the company's stock.

CVS Health Stock Down 0.8%

Shares of CVS stock opened at $76.86 on Tuesday. The stock has a 50 day moving average of $71.05 and a 200 day moving average of $67.39. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The stock has a market cap of $97.48 billion, a P/E ratio of 21.47, a P/E/G ratio of 0.85 and a beta of 0.60. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $79.20.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health's quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the business earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date is Thursday, October 23rd. CVS Health's dividend payout ratio (DPR) is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.